A61K 2039/6062
Muramyl peptides
Official title: {Muramyl peptides}
A61K2039/6062 (Muramyl peptides) appears on 9 US grants and 5 published applications in this corpus.
Search patents in A61K- Granted patents
- 9
- Published applications
- 5
- Assignees
- 9
- Inventors
- 22
- Latest grant
- 24 Apr 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and methods for treatment of neoplastic disease24 Apr 2018US 9,950,025 B2Innate Immunotherapeutics Limited
- Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide6 Feb 2018US 9,884,084 B2Snu R&Db Foundation
- Compositions and methods for treatment of neoplastic disease16 Aug 2016US 9,415,061 B2Innate Immunotherapeutics Limited
- Anti-infective agents and uses thereof29 Apr 2014US 8,709,448 B2Innate Immunotherapeutics Limited
- Non-malignant cells coupled to adjuvants and their use in a method to induce anti-tumor immunity4 May 1993US 5,208,022 AState University of New York (Suny)
- Compositions and methods for treatment of neoplastic disease8 Dec 2016US 2016/0354424 A1Innate Immunotherapeutics Limited
- Bone loss preventing and bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide21 May 2015US 2015/0141352 A1Snu R&Db Foundation
- Compositions and methods for treatment of neoplastic disease7 Jul 2011US 2011/0165250 A1Innate Immunotherapeutics Limited
- Anti-Infective Agents and Uses Thereof10 Feb 2011US 2011/0033494 A1Innate Therapeutics Limited
- Thomsen-friedenreich disaccharide modified immunogen (tfd), preparation procedure, compositions comprising it, uses, and treatment methods25 Nov 2010US 2010/0297159 A1Consejo Nacional De Investigaciones Cietificas Y Tecnicas (Conicet)
Most cited
By later US patents
- Antigen derivatives and processes for their preparation17US 4,446,128 ACiba-Geigy Corporation · 1984
- Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them12US 4,639,512 AAgence Nationale de Valorisation de la Recherche · 1987
- Antigen derivatives and processes for their preparation9US 4,397,844 ACiba-Geigy Corporation · 1983
- Antigen derivatives and processes for their preparation4US 4,574,058 ACiba-Geigy Corporation · 1986
- Non-malignant cells coupled to adjuvants and their use in a method to induce anti-tumor immunity4US 5,208,022 AState University of New York (Suny) · 1993